P3 Health Partners (NASDAQ:PIII - Get Free Report) is set to announce its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.03) per share for the quarter. P3 Health Partners has set its FY 2024 guidance at EPS.Persons that are interested in participating in the company's earnings conference call can do so using this link.
P3 Health Partners (NASDAQ:PIII - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.07). P3 Health Partners had a negative return on equity of 43.19% and a negative net margin of 4.95%. The company had revenue of $379.16 million during the quarter, compared to analysts' expectations of $364.50 million. On average, analysts expect P3 Health Partners to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
P3 Health Partners Stock Performance
PIII stock traded down $0.01 during midday trading on Tuesday, hitting $0.35. 104,654 shares of the company traded hands, compared to its average volume of 447,238. The business has a 50 day simple moving average of $0.42 and a 200-day simple moving average of $0.52. The stock has a market capitalization of $125.56 million, a price-to-earnings ratio of -0.54 and a beta of 1.15. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.80. P3 Health Partners has a twelve month low of $0.30 and a twelve month high of $1.78.
Insider Transactions at P3 Health Partners
In other news, major shareholder Pacific Founders Ugp I. Chicago bought 80,000 shares of the business's stock in a transaction on Wednesday, September 11th. The shares were purchased at an average price of $0.56 per share, for a total transaction of $44,800.00. Following the purchase, the insider now owns 77,025,438 shares of the company's stock, valued at approximately $43,134,245.28. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last ninety days, insiders purchased 400,000 shares of company stock worth $205,600. 17.86% of the stock is currently owned by company insiders.
P3 Health Partners Company Profile
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Featured Stories
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
